Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1958 1
1959 1
1960 1
1961 1
1962 4
1963 1
1964 2
1965 1
1966 1
1967 4
1968 4
1969 3
1970 1
1971 6
1972 5
1973 4
1974 15
1975 6
1976 12
1977 10
1978 9
1979 7
1980 4
1981 22
1982 18
1983 15
1984 25
1985 29
1986 45
1987 31
1988 40
1989 51
1990 49
1991 52
1992 54
1993 49
1994 75
1995 72
1996 79
1997 88
1998 88
1999 93
2000 87
2001 120
2002 137
2003 144
2004 198
2005 207
2006 307
2007 304
2008 351
2009 368
2010 442
2011 493
2012 602
2013 641
2014 710
2015 801
2016 805
2017 839
2018 952
2019 1110
2020 1303
2021 1501
2022 1722
2023 484
Text availability
Article attribute
Article type
Publication date

Search Results

14,113 results
Results by year
Filters applied: . Clear all
Page 1
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Berardi RA, Shead DA, Freedman-Cass DA. Schaeffer EM, et al. Among authors: cheng hh. J Natl Compr Canc Netw. 2022 Dec;20(12):1288-1298. doi: 10.6004/jnccn.2022.0063. J Natl Compr Canc Netw. 2022. PMID: 36509074
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Gillessen S, Bossi A, Davis ID, de Bono J, Fizazi K, James ND, Mottet N, Shore N, Small E, Smith M, Sweeney C, Tombal B, Antonarakis ES, Aparicio AM, Armstrong AJ, Attard G, Beer TM, Beltran H, Bjartell A, Blanchard P, Briganti A, Bristow RG, Bulbul M, Caffo O, Castellano D, Castro E, Cheng HH, Chi KN, Chowdhury S, Clarke CS, Clarke N, Daugaard G, De Santis M, Duran I, Eeles R, Efstathiou E, Efstathiou J, Ngozi Ekeke O, Evans CP, Fanti S, Feng FY, Fonteyne V, Fossati N, Frydenberg M, George D, Gleave M, Gravis G, Halabi S, Heinrich D, Herrmann K, Higano C, Hofman MS, Horvath LG, Hussain M, Jereczek-Fossa BA, Jones R, Kanesvaran R, Kellokumpu-Lehtinen PL, Khauli RB, Klotz L, Kramer G, Leibowitz R, Logothetis CJ, Mahal BA, Maluf F, Mateo J, Matheson D, Mehra N, Merseburger A, Morgans AK, Morris MJ, Mrabti H, Mukherji D, Murphy DG, Murthy V, Nguyen PL, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Pezaro C, Poon DMC, Pritchard CC, Rabah DM, Rathkopf D, Reiter RE, Rubin MA, Ryan CJ, Saad F, Pablo Sade J, Sartor OA, Scher HI, Sharifi N, Skoneczna I, Soule H, Spratt DE, Srinivas S, Sternberg CN, Steuber T, Suzuki H, Sydes MR, Taplin ME, Tilki D, Türkeri L, Turco F, Uemura H, Uemura H,… See abstract for full author list ➔ Gillessen S, et al. Among authors: cheng hh. Eur Urol. 2023 Mar;83(3):267-293. doi: 10.1016/j.eururo.2022.11.002. Epub 2022 Dec 6. Eur Urol. 2023. PMID: 36494221 Free article.
Bioresponsive Immunotherapeutic Materials.
Han J, Sheng T, Zhang Y, Cheng H, Gao J, Yu J, Gu Z. Han J, et al. Among authors: cheng h. Adv Mater. 2023 Jan 14:e2209778. doi: 10.1002/adma.202209778. Online ahead of print. Adv Mater. 2023. PMID: 36639983 Review.
AIM2 and Psoriasis.
Zhang Y, Xu X, Cheng H, Zhou F. Zhang Y, et al. Among authors: cheng h. Front Immunol. 2023 Jan 18;14:1085448. doi: 10.3389/fimmu.2023.1085448. eCollection 2023. Front Immunol. 2023. PMID: 36742336 Free PMC article. Review.
Antigen self-presenting nanovaccine for cancer immunotherapy.
Liang X, Cheng H, Liu C, Liu G. Liang X, et al. Among authors: cheng h. Sci Bull (Beijing). 2022 Aug 31;67(16):1611-1613. doi: 10.1016/j.scib.2022.07.018. Epub 2022 Jul 14. Sci Bull (Beijing). 2022. PMID: 36546034 No abstract available.
[A new xanthone from Hypericum lagarocladum].
Deng JT, Zhou TX, Yang YC, Han QD, Cheng HT, Wang Q, Yang XZ. Deng JT, et al. Among authors: cheng ht. Zhongguo Zhong Yao Za Zhi. 2022 Oct;47(20):5544-5549. doi: 10.19540/j.cnki.cjcmm.20220418.202. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36471971 Chinese.
Expert Consensus on the Clinical Use of Pulse Wave Velocity in Asia.
Park JB, Sharman JE, Li Y, Munakata M, Shirai K, Chen CH, Jae SY, Tomiyama H, Kosuge H, Bruno RM, Spronck B, Kario K, Lee HY, Cheng HM, Wang J, Budoff M, Townsend R, Avolio AP. Park JB, et al. Among authors: cheng hm. Pulse (Basel). 2022 Nov 22;10(1-4):1-18. doi: 10.1159/000528208. eCollection 2022 Dec. Pulse (Basel). 2022. PMID: 36660436 Free PMC article.
14,113 results
You have reached the last available page of results. Please see the User Guide for more information.